Tompkins Financial’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-965
Closed -$171K 431
2020
Q1
$171K Sell
965
-200
-17% -$37.7K 0.04% 157
2019
Q4
$223K Buy
1,165
+995
+585% +$179K 0.04% 161
2019
Q3
$29K Hold
170
0.01% 270
2019
Q2
$28K Hold
170
0.01% 279
2019
Q1
$25K Hold
170
﹤0.01% 299
2018
Q4
$23K Hold
170
0.01% 290
2018
Q3
$32K Hold
170
0.01% 283
2018
Q2
$28K Hold
170
0.01% 313
2018
Q1
$29K Hold
170
0.01% 298
2017
Q4
$28K Buy
+170
New +$30.5K 0.01% 266
2016
Q4
Sell
-1,370
Closed -$316K 401
2016
Q3
$316K Buy
1,370
+1,020
+291% +$249K 0.09% 120
2016
Q2
$81K Buy
350
+125
+56% +$28.8K 0.02% 204
2016
Q1
$60K Sell
225
-70
-24% -$20K 0.02% 225
2015
Q4
$92K Sell
295
-109
-27% -$32.5K 0.03% 208
2015
Q3
$110K Hold
404
0.04% 186
2015
Q2
$122K Sell
404
-72
-15% -$21.5K 0.03% 185
2015
Q1
$141K Buy
+476
New +$136K 0.04% 180

Other funds holding AGN

Tompkins Financial's AGN Position: Q2 2020 in Review

Tompkins Financial sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 965 shares — an estimated $171K sold.

Tompkins Financial first reported a position in AGN in Q1 2015 and held it in 17 quarters. The position peaked at $316K in Q3 2016. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Tompkins Financial reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Tompkins Financial sold 965 Allergan plc shares in Q2 2020, an estimated $171K.
  • Tompkins Financial first reported a position in Allergan plc in Q1 2015 and held it in 17 quarters.
  • Tompkins Financial's Allergan plc position peaked at $316K in Q3 2016.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Tompkins Financial's 13F filing for Q2 2020, filed 29 Jul 2020.